Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 499 JPY 2.18% Market Closed
Market Cap: 86.1B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Kyorin Holdings Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kyorin Holdings Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
Cash from Operating Activities
-ÂĄ3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Operating Activities
ÂĄ876.3B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Operating Activities
ÂĄ583.9B
CAGR 3-Years
73%
CAGR 5-Years
25%
CAGR 10-Years
17%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Operating Activities
ÂĄ379.8B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
8%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Operating Activities
ÂĄ409.9B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
27%
Astellas Pharma Inc
TSE:4503
Cash from Operating Activities
ÂĄ172.9B
CAGR 3-Years
-19%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
86.1B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 168.03 JPY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
-3.5B JPY

Based on the financial report for Sep 30, 2024, Kyorin Holdings Inc's Cash from Operating Activities amounts to -3.5B JPY.

Back to Top